11. Antithrombotic therapies

Six versus twelve months DAPT after DES for STEMI

DAPT-STEMI
Objective
to compare six months DAPT versus 12 months DAPT
Study
multicentre, open-label, non-inferiority randomised controlled trial
Population
patients treated with zoterolimus eluting stents for STEMI + event free at 6 months
Endpoints
death, any myocardial infarction, any revascularisation, stroke, major bleeding at 2 years
Conclusion
6 months DAPT was not inferior to 12 months DAPT
Kedhi et al. BMJ. 2018;363:k3793
follow us
Copyright © 2025 Europa Group – All rights reserved.
The content of this site is intended for health care professionals.